Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine
出版年份 2015 全文链接
标题
Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine
作者
关键词
-
出版物
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 30, Issue suppl 4, Pages iv105-iv112
出版商
Oxford University Press (OUP)
发表日期
2015-07-24
DOI
10.1093/ndt/gfv210
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Epidemiological Perspectives of Diabetes
- (2015) Ziqi Tao et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes
- (2015) Michelle J. Pena et al. PLoS One
- Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist
- (2014) J. Hoekman et al. Clinical Journal of the American Society of Nephrology
- Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors
- (2014) Gudbjörg Andrésdóttir et al. DIABETES CARE
- Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
- (2014) Melanie P. Chin et al. JOURNAL OF CARDIAC FAILURE
- Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
- (2014) Monika A. Niewczas et al. KIDNEY INTERNATIONAL
- Correction: The effect of RAAS blockade on the progression of diabetic nephropathy
- (2014) Sara S. Roscioni et al. Nature Reviews Nephrology
- Applications of CYP450 Testing in the Clinical Setting
- (2013) C. F. Samer et al. Molecular Diagnosis & Therapy
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
- (2012) S. S. Roscioni et al. DIABETOLOGIA
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Perspectives on Systems Biology Applications in Diabetic Kidney Disease
- (2012) Claudiu V. Komorowsky et al. Journal of Cardiovascular Translational Research
- Phase III and submission failures: 2007–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Global variation in renal replacement therapy for end-stage renal disease
- (2011) F. J. Caskey et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Urinary Proteomics Based on Capillary Electrophoresis-Coupled Mass Spectrometry in Kidney Disease: Discovery and Validation of Biomarkers, and Clinical Application
- (2010) Harald Mischak et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes
- (2010) L. C. Plantinga et al. Clinical Journal of the American Society of Nephrology
- Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs
- (2010) Kim Taverne et al. Expert Opinion on Drug Metabolism & Toxicology
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation